Physician profile
Rupal Parikh
NPI 1154770543
$4,979.15
in general payments reported to CMS, 2019-2025
12 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $618 · 2022: $458 · 2023: $2,614 · 2024: $18.74 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,071 · Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,070.84 |
| Food and Beverage | $1,718.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,866.28 | 2022-2025 | Indigo System |
| Medtronic, INC. | $651.13 | 2021-2022 | |
| Inari Medical, INC. | $626.54 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $190.87 | 2023-2025 | Spinejack, Omnicurve, Optablate |
| Siemens Medical Solutions USA, INC. | $137.84 | 2025 | Varian Cryocare Touch System, Embozene |
| Boston Scientific Corporation | $123.41 | 2023 | Embold Fibered, Eluvia |
| Medical Device Business Services, INC. | $114.00 | 2019 | |
| Philips North America LLC | $106.88 | 2021 | |
| Bard Peripheral Vascular, INC. | $78.77 | 2023 | Venovo |
| Baylis Medical Technologies INC. | $37.11 | 2025 | |
| Trisalus Life Sciences, INC. | $27.59 | 2023 | Trinav Infusion System |
| Terumo Medical Corporation | $18.73 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupal Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.